Rock Springs Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,000,000
| Closed | -$24.4M | – | 154 |
|
|
2021
Q2 | $24.4M | Sell |
1,000,000
-76,200
| -7% | -$1.86M | 0.48% | 67 |
|
|
2021
Q1 | $27.8M | Sell |
1,076,200
-536,300
| -33% | -$13.8M | 0.61% | 58 |
|
|
2020
Q4 | $86.2M | Buy |
1,612,500
+39,300
| +2% | +$2.1M | 1.83% | 10 |
|
|
2020
Q3 | $64.9M | Buy |
1,573,200
+518,200
| +49% | +$21.4M | 1.65% | 13 |
|
|
2020
Q2 | $51.1M | Buy |
1,055,000
+30,000
| +3% | +$1.45M | 1.4% | 17 |
|
|
2020
Q1 | $43.3M | Buy |
1,025,000
+355,000
| +53% | +$15M | 1.79% | 12 |
|
|
2019
Q4 | $28.7M | Buy |
670,000
+483,000
| +258% | +$20.7M | 0.91% | 45 |
|
|
2019
Q3 | $6.73M | Buy |
+187,000
| New | +$6.73M | 0.27% | 89 |
|
|
2017
Q4 | – | Sell |
-182,000
| Closed | -$6.86M | – | 145 |
|
|
2017
Q3 | $6.86M | Buy |
182,000
+8,000
| +5% | +$301K | 0.32% | 90 |
|
|
2017
Q2 | $4.85M | Buy |
+174,000
| New | +$4.85M | 0.25% | 99 |
|
|
2014
Q1 | – | Sell |
-31,418
| Closed | -$785K | – | 76 |
|
|
2013
Q4 | $785K | Buy |
+31,418
| New | +$785K | 0.28% | 66 |
|